Hims stock pre-market drops over 17%, Novo Nordisk states it has filed a lawsuit against Hims & Hers generic.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hims stock drops over 17% in pre-market trading on U.S. exchanges
Hims stock pre-market drops over 17%, Novo Nordisk states it has filed a lawsuit against Hims & Hers generic.